340B Insight Podcast
340B Insight is 340B Health’s podcast, providing our members and supporters with timely news updates and discussion around the 340B drug pricing program. The podcast enables listeners to stay current and expand their knowledge of 340B to help them serve their patients and communities and remain compliant with rules and requirements. New episodes are published twice per month and include news update segments and in-depth interviews with leading experts including health care practitioners, policy and legal experts, public policymakers, and our expert staff.
Have a question or suggestion for 340B Insight? Email us at: podcast@340bhealth.org
Podcast sponsorship opportunities are available. Email to learn more: robin.hayes@340bhealth.org
Follow 340B Health on Twitter, Facebook, and LinkedIn
Episodes
-
Episode 52: U.S. Supreme Court Decision on Medicare Cuts to 340B
The U.S. Supreme Court issued a major decision earlier this month regarding Medicare Part B cuts for 340B drugs. We’re joined by Amanda Nagrotsky, senior counsel for 340B Health to understand what implications this decision holds for 340B hospitals. (Transcript)
Read more -
Episode 51: How Data Analytics Support Your 340B Program
This week, we are joined by Bhupinder Kaur, business analyst and 340B coordinator with NorthBay Healthcare Group in California. Bhupinder presented at the 340B Coalition 2021 Winter Conference on data analysis and shares with us important information that 340B professionals need to know about best practices. Before the interview, we highlight a recently published op-ed on the critical role of 340B savings during the height of the COVID-19 pandemic. (Transcript)
Read more -
Episode 50: A 340B Update from the State Level
It’s our 50th episode! This week we are joined by Amanda Sellers Smith, legal counsel for 340B Health. Amanda is responsible for tracking and responding to 340B state legislative and regulatory actions. Even though 340B is a federal program, its close relationship with state Medicaid programs often keeps it on the agendas of state lawmakers and health officials. Amanda discusses what listeners need to know about recent 340B activity in the states. Before the interview, we give an update on recent briefs to appeals courts that are considering cases about the contract pharmacy dispute, and we note that another drug company has received an official violation letter from HRSA for its 340B restrictions. (Transcript)
Read more -
Episode 49: Using 340B Savings to Tackle Health Disparities
This week, we are joined by Coletta Barrett, vice president of mission at Our Lady of the Lake Regional Medical Center. Our Lady of the Lake (OLOL) is using its 340B savings to pursue health equity initiatives. Coletta shares best practices and provides inspiration for how 340B professionals can work toward eliminating health disparities in their hospitals and communities. Before the interview, we share updates on a new 340B Health survey report demonstrating the harm to hospitals and patients of drug company restrictions on discounts for drugs dispensed at community and specialty contract pharmacies. (Transcript)
Read more -
Episode 48: How You Can Advocate for 340B – and Why You Should
This week, we are joined by Laurie Chiumento, director of federal relations and healthcare policy at UR Medicine, the health system for the University of Rochester in New York. Laurie is an expert on how health systems and hospitals can advocate and promote their legislative priorities to members of Congress. She shares advice to hospitals that are preparing to speak with their elected officials about 340B issues or are considering doing so. She also discusses advocacy days in D.C., opportunities to host elected officials for visits to your hospital, and the 2022 midterm elections. Before the interview, we provide an update on the 340B community pharmacy dispute court cases. (Transcript)
Read more -
Episode 47: Celebrating the 340B Ceiling Price Website’s Success
This week, we are joined by Steven Miller, vice president of pharmacy services at 340B Health. April 1 was the third anniversary of the federal 340B ceiling price website’s launch. Steve discusses how this database has become an invaluable tool for 340B drug pricing transparency. Before the interview, our news update shares how HRSA escalated enforcement actions against one of the companies restricting 340B discounts. The update also notes the release of 340B Health’s 2021 annual survey report on how hospitals are using their savings. (Transcript)
Read more